aod9604 hgh fragment number AOD-9604 — Research Peptide, Third-Party Tested AOD-9604 | Synthetic hGH Fragment

Tirzepatide Once Weekly for the Treatment of Obesity

Research on the compound indicates it stimulates the former while inhibiting the latter, acting locally on adipose tissue in a manner that mirrors the fat-metabolizing region of full-length growth hormone without activating the receptor pathway responsible for growth and blood sugar effects

The cycling protocols commonly recommended are partly based on this theoretical concern, though actual tolerance development has not been documented

8 weeks: ~4 vials 12 weeks: ~6 vials 16 weeks: ~8 vials Insulin Syringes (U-100, 1 mL) Per injection: 1 syringe 8 weeks (once daily): ~56 syringes 16 weeks (once daily): ~112 syringes Bacteriostatic Water (10 mL bottles) Use ~3.0 mL per 5 mg vial for reconstitution